Patient Trajectories for Older Adults Admitted to Hospital for Alcohol-related Problems
NCT ID: NCT04164940
Last Updated: 2023-11-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2019-10-23
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Norwegian health authorities have issued mandates ordering the regional health trusts to implement strategies in somatic hospital wards, mental health services and drug treatment services to identify and treat alcohol and drug problems affecting the patients' health.
In this observational study we will explore patient trajectories three years prior to and three years after an admittance to hospital where risky or harmful alcohol consumption is identified and brief interventions are delivered. Hospitals that have implemented such strategies are invited to the study. Patient trajectories are studied in national health registries. This will provide important knowledge on what characterizes the patients identified, and what happens after they have received a brief intervention related to a hospital admittance.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The recruited hospitals will have different strategies for identification of and interventions for alcohol-related health problems, and the choice of methods is thus outside of our control. All inhabitants in Norway are registered with a personal identification number. This individual identifier makes the linkage between the participants and the different registries possible. Data from these registries will enable the study of serious incidents, as well as of diagnoses, medications and other treatments, welfare and benefits, and causes of death. Data will be gathered three years retrospectively and 3 years prospectively, related to the index hospital stay where alcohol is addressed and a brief intervention is delivered.
Inclusion criteria for patients are age 21+, no previous treatment history for drug or alcohol problems in specialized health care, admitted to medical or surgical hospital ward, identified risky or harmful alcohol consumption, accepting an alcohol intervention and accepting study participation. Baseline data collected are AUDIT C, question no 10 from the full AUDIT and classification of alcohol consumption (risky or harmful). All other variables are extracted from the national health registries (reimbursement data from primary health care and secondary health care, prescription database, Cause of death registry, Norwegian Trauma Registry and social security data, marital status, professional status).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Age 21-30
Patients aged 21-30 when admitted to hospital and receiving brief alcohol intervention
Brief alcohol intervention
Brief alcohol intervention already implemented in daily routine by the individual hospitals.
Age 31-40
Patients aged 31-40 when admitted to hospital and receiving brief alcohol intervention
Brief alcohol intervention
Brief alcohol intervention already implemented in daily routine by the individual hospitals.
Age 41-50
Patients aged 41-50 when admitted to hospital and receiving brief alcohol intervention
Brief alcohol intervention
Brief alcohol intervention already implemented in daily routine by the individual hospitals.
Age 51-60
Patients aged 51-60 when admitted to hospital and receiving brief alcohol intervention
Brief alcohol intervention
Brief alcohol intervention already implemented in daily routine by the individual hospitals.
Age 61-70
Patients aged 61-70 when admitted to hospital and receiving brief alcohol intervention
Brief alcohol intervention
Brief alcohol intervention already implemented in daily routine by the individual hospitals.
Age 71-80
Patients aged 71-80 when admitted to hospital and receiving brief alcohol intervention
Brief alcohol intervention
Brief alcohol intervention already implemented in daily routine by the individual hospitals.
Age 81 and older
Patients aged 81 and older when admitted to hospital and receiving brief alcohol intervention
Brief alcohol intervention
Brief alcohol intervention already implemented in daily routine by the individual hospitals.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Brief alcohol intervention
Brief alcohol intervention already implemented in daily routine by the individual hospitals.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Helse Vest
OTHER
Helse Fonna
OTHER
Helse Møre og Romsdal HF
OTHER_GOV
Sorlandet Hospital HF
OTHER_GOV
Helse Sor-Ost
OTHER_GOV
Lovisenberg Diakonale Hospital
OTHER
Oslo University Hospital
OTHER
Vestre Viken Hospital Trust
OTHER
Helse Stavanger HF
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Torgeir G Lid, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Helse Stavanger HF
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
StavangerUH
Stavanger, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID734
Identifier Type: -
Identifier Source: org_study_id